|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 |
| (11) | Number of the document | 2524231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11700467.1 |
| Date of filing the European patent application | 2011-01-04 | |
| (97) | Date of publication of the European application | 2012-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/020080 |
| Date | 2011-01-04 |
| (87) | Number | WO 2011/087926 |
| Date | 2011-07-21 |
| (30) | Number | Date | Country code |
| 294615 P | 2010-01-13 | US |
| (72) |
COUGHLIN, Christina Marie, US
BERKENBLIT, Anna, US
FEINGOLD, Jay Marshall, US
JOHNSTON, Daniel Stephen, US
STRAHS, Andrew Louis, US
ZACHARCHUK, Charles Michael, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |